AI-Powered Investment Platform

SlimScan – AI CAN SLIM Growth Stock Screener for US Stocks
Analyze top U.S. growth stocks using CAN SLIM principles, enhanced with real-time data and AI-powered pattern recognition.

Start Your Investment Journey Today with Free Access to 10 Stocks or Unlock Pro Plans for Full Platform Access

Real-time data

Rated 4.9/5

SlimScan 50 Stock Screener with Real-time Data

AI Pattern Recognition for Entry/Exit Signals

Comprehensive Stock Analysis & Risk Management

Premium Stocks

AI Pattern Recognition

Market Monitoring

Try Live Screener View Plans

Trusted by active growth investorsBuilt for serious CAN SLIM-style traders

SlimScan 50 – CAN SLIM-Based Screener

Access 50+ top-rated U.S. growth stocks selected using CAN SLIM principles, with real-time prices, key technical indicators, and risk assessments.

Real-time market dataTechnical indicatorsRisk assessments

Live Demo

Real-time Data•Live Updates

Try Now

Live Market Data

AI Analysis Active

Professional Trading Tools

Tools That Give You an Edge in the Market

Everything you need to make informed investment decisions with confidence

Real-time market data

SlimScan 50 – CAN SLIM-Based Screener

Access 50+ top-rated U.S. growth stocks selected using CAN SLIM principles, with real-time prices, key technical indicators, and risk assessments.

Real-time market data

Technical indicators

Risk assessments

Explore Now

Real-time Data

Verified

50+

Stocks

AI-Powered

AI Pattern Analysis

Weekly AI-powered technical pattern recognition and entry point recommendations for Pro members with machine learning insights.

Pattern recognition

Entry point alerts

Risk management

Upgrade to Pro

AI Analysis Active

Verified

94%

Accuracy

Professional Tools

Detailed Stock Checkup

Comprehensive fundamental and technical analysis with professional ratings, institutional ownership data, and interactive charts.

Financial health scores

Ownership analysis

Performance metrics

View Analysis

Real-time Data

Verified

50+

Stocks

Start Your Investment Journey Today

Begin with FREE access to 10 stocks, or unlock PRO for full platform access

Start Free Trial Upgrade to Pro

Latest Market News

Stay updated with the latest market news and stock analysis

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

Stock News

22/04/2026

1,451

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

Kevin Warsh Faces Intense Senate Scrutiny in a High-Stakes Fight Over the Future of the Federal ReserveKevin Warsh, former Federal Reserve official an...

View All News

Start Your Investment Journey Today

Begin with FREE access to 10 stocks, or unlock PRO for full platform access

Free Plan

Access to 10 top-rated stocks

Basic screening with fundamental analysis
Real-time market data and quotes
Weekly performance updates

POPULAR

Pro Plan

Full platform access

50+ premium stocks with detailed analysis
AI-powered pattern recognition
Real-time alerts and notifications

Start Free Trial Upgrade to Pro

Bank-level security

Real-time data

Risk management

SlimScan – AI CAN SLIM Growth Stock Screener for US Stocks
Analyze top U.S. growth stocks using CAN SLIM principles, enhanced with real-time data and AI-powered pattern recognition.

Start Your Investment Journey Today with Free Access to 10 Stocks or Unlock Pro Plans for Full Platform Access

SlimScan 50 – CAN SLIM-Based Screener

Tools That Give You an Edge in the Market

SlimScan 50 – CAN SLIM-Based Screener

AI Pattern Analysis

Detailed Stock Checkup

Start Your Investment Journey Today

Latest Market News

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

Start Your Investment Journey Today

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

SRx Health Solutions Expands Strategic Portfolio with Investment in Astro Investment XVII, Strengthening Its Position in Healthcare Innovation

Amneal Pharmaceuticals Beats Q1 2026 Estimates as Revenue Climbs, Profit Improves, and Kashiv BioSciences Deal Signals Bigger Biosimilars Push

Otis Worldwide Misses Q1 EPS Estimates but Shows Strong Service Momentum and Revenue Growth in Detailed First-Quarter Update

Ferrexpo Shares Tumble as Miner Warns Equity Raise May Be Its Only Realistic Lifeline

Gold Market Analysis April 22: Key Intraday Price Levels and Strategic Entry Points for Active Traders

Finnair Q1 2026 Earnings Rewrite: Stronger Revenue, Surging Asia Demand, and a Cautious but Stable Full-Year Outlook

Pinewood Technologies Group Delivers Strong FY25 Growth as AI Integration and North America Expansion Drive Momentum

Faruqi & Faruqi LLP Issues Critical Reminder to Coty Investors Ahead of May 22, 2026 Securities Class Action Deadline

Palantir vs. CrowdStrike: Which AI Stock Looks Stronger in 2026—and Which One Could Hurt Investors if Growth Slows?

SlimScan – AI CAN SLIM Growth Stock Screener for US StocksAnalyze top U.S. growth stocks using CAN SLIM principles, enhanced with real-time data and AI-powered pattern recognition.

Start Your Investment Journey Today with Free Access to 10 Stocks or Unlock Pro Plans for Full Platform Access

SlimScan 50 – CAN SLIM-Based Screener

Tools That Give You an Edge in the Market

SlimScan 50 – CAN SLIM-Based Screener

AI Pattern Analysis

Detailed Stock Checkup

Start Your Investment Journey Today

Latest Market News

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

Start Your Investment Journey Today

Kevin Warsh’s Federal Reserve Nomination Heads for a Tough Senate Test as Lawmakers Scrutinize Wealth, Transparency, and Central Bank Independence

SRx Health Solutions Expands Strategic Portfolio with Investment in Astro Investment XVII, Strengthening Its Position in Healthcare Innovation

Amneal Pharmaceuticals Beats Q1 2026 Estimates as Revenue Climbs, Profit Improves, and Kashiv BioSciences Deal Signals Bigger Biosimilars Push

Otis Worldwide Misses Q1 EPS Estimates but Shows Strong Service Momentum and Revenue Growth in Detailed First-Quarter Update

Ferrexpo Shares Tumble as Miner Warns Equity Raise May Be Its Only Realistic Lifeline

Gold Market Analysis April 22: Key Intraday Price Levels and Strategic Entry Points for Active Traders

Finnair Q1 2026 Earnings Rewrite: Stronger Revenue, Surging Asia Demand, and a Cautious but Stable Full-Year Outlook

Pinewood Technologies Group Delivers Strong FY25 Growth as AI Integration and North America Expansion Drive Momentum

Faruqi & Faruqi LLP Issues Critical Reminder to Coty Investors Ahead of May 22, 2026 Securities Class Action Deadline

Palantir vs. CrowdStrike: Which AI Stock Looks Stronger in 2026—and Which One Could Hurt Investors if Growth Slows?

SlimScan – AI CAN SLIM Growth Stock Screener for US Stocks
Analyze top U.S. growth stocks using CAN SLIM principles, enhanced with real-time data and AI-powered pattern recognition.